Effect of Rifampin-Isoniazid-Containing Antituberculosis Therapy on Efavirenz Pharmacokinetics in HIV-Infected Children 3 to 14 Years Old

We compared efavirenz pharmacokinetic (PK) parameters in children with tuberculosis (TB)/human immunodeficiency virus (HIV) coinfection on and off first-line antituberculosis therapy to that in HIV-infected children. Children 3 to 14 years old with HIV infection, with and without TB, were treated wi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Antimicrob Agents Chemother
Hlavní autoři: Kwara, Awewura, Yang, Hongmei, Antwi, Sampson, Enimil, Anthony, Gillani, Fizza S., Dompreh, Albert, Ortsin, Antoinette, Opoku, Theresa, Bosomtwe, Dennis, Sarfo, Anima, Wiesner, Lubbe, Norman, Jennifer, Alghamdi, Wael A., Langaee, Taimour, Peloquin, Charles A., Court, Michael H., Greenblatt, David J.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2018
Témata:
Clinical Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325194/
https://ncbi.nlm.nih.gov/pubmed/30397066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01657-18
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky